Clinical Trial Update: Open-label Pilot Clinical Trial of Oral Ivermectin to Treat Atopic Dermatitis [Phase 2]

View source ↗

Summary

An open-label Phase 2 pilot trial evaluating oral ivermectin for atopic dermatitis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• IVERMECTIN (Ivermectin)

Snippet

Sponsor: Stanford University | Conditions: Atopic Dermatitis | Phase 2 | Status: WITHDRAWN